Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Cureus|December 31, 2024
Peritoneal Dissemination and Malignant Ascites in Duodenal Cancer Successfully Treated With Adoptive Cell Therapy Using WT1- and MUC1-Pulsed Dendritic Cells and Activated T Cells With No Adverse Effects: A Case ReportYohsuke Yagawa, Yasunobu Kobayashi, Izumi Fujita, et al.
Therapeutic Advances in Chronic Disease|July 21, 2021
Long-term outcomes of antibiotic combination therapy for ulcerative colitisYuriko Nishikawa, Nobuhiro Sato, Shintaro Tsukinaga, et al.
Bioscience of Microbiota, Food and Health|July 20, 2022
Growth of various obligate and facultative anaerobic intestinal bacteria in cell culture medium under aerobic and anaerobic culture conditionsToshifumi Ohkusa, Shigeo Koido, Sankichi Horiuchi, et al.
Breast Cancer Research : BCR|January 27, 2012
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markersDesheng Weng, Jeffrey H Penzner, Baizheng Song, et al.
Plos One|October 25, 2014
Combinatorial contextualization of peptidic epitopes for enhanced cellular immunityMasaki Ito, Kazumi Hayashi, Eru Adachi, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2007
Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparationSadamu Homma, Yukiko Sagawa, Hideo Komita, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cellsJianchuan Xia, Yasuhiro Tanaka, Shigeo Koido, et al.
Oncology Reports|August 5, 2015
Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumorsHideo Komita, Shigeo Koido, Kazumi Hayashi, et al.
Internal Medicine (Tokyo, Japan)|May 17, 2006
A Japanese case of familial Mediterranean fever with onset in the fiftiesTateki Yamane, Kan Uchiyama, Daigo Hata, et al.
Oncoimmunology|May 6, 2015
Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancerShigeo Koido, Sadamu Homma, Masato Okamoto, et al.
Pageof 15